FMCG stocks fall as HUL's Q2 results show 7 per cent decline in volume growth. Experts, Lancelot D'Cunha, CEO of ITI Health Management, and Suresh A Mahadevan, head-India equities at UBS Securities, discuss whether BHEL's second quarter results will be as per expectations.